 2022 Guidance Meeting Announcement
Centene anticipates that subsequent events and developments may cause its estimates to change. The company will invite sell-side analysts to participate in person in New York and virtually in a 2022 guidance meeting to be held on December 10.

# Third Quarter Results
In the third quarter, Centene generated revenue of $32.4 billion and HBR of 88.1% and adjusted earnings per share of $1.26. The performance provides a strong foundation for the company's value creation plan and it remains committed to its margin goals.

# Product Line Performance
Centene's diversified enterprise has been able to manage through the volatility of COVID, pent-up demand and resulting 2021 marketplace pressure. The company's adjusted SG&A expense ratio was 8.6% in the third quarter with higher short-term variable incentive compensation costs compared to Q2.

# Vaccine Mandates
Centene has been a leader on the critical issue of mandating vaccinations and continues to support its members in assessing the vaccine. The company also continues to participate in national outreach and campaigns such as the Pro Football Hall of Fame NESCO.

# 2022 Outlook
Centene expects modest adjusted earnings per share growth next year. The company looks forward to providing more